TP53 and head and neck cancer: Similarly, treatment of HPV-transformed cervical and head and neck cancer cells with 5-azaD reduced expression of HPV genes (E6 and E7) and increased target proteins including TP53 and p21 resulted in reduction of proliferation rates [19].